The SureTouch Breast Exam provides women with peace of mind because they receive immediate results about their breast health. Women walk away from a SureTouch Breast Exam empowered with knowledge which, in the case of a breast abnormality, could save their lives. 

According to the American Cancer Society, this year alone, about 231,840 new cases of invasive breast cancer will be diagnosed in U.S. women. Sadly, it is projected that breast cancer will take the lives of over 40,000 of these women.

While the survival rate for stage 4 breast cancer is 22%, the survival rate for stage 1 breast cancer is 98% -100%.

The good news is that with its advanced breast screening tactile technology, SureTouch can provide early detection of breast abnormalities.

In the U.S. alone, we lose nearly 40,000 of our mothers, daughters, sisters and wives to breast cancer every year. SureTouch is a game-changer in the fight against breast cancer.

SureTouch is an FDA-cleared breakthrough in breast screening technology that is safe and reliable.

The SureTouch device is passive in that it does not introduce any additional energy into the breast. The tactile technology produces no discomfort, is radiation free, does not require a contrast agent, and over the past decade there have been no adverse reports concerning the safety and use of SureTouch.

SureTouch does not require painful compression in an uncomfortable position.

The SureTouch Breast Exam is gentle and is performed while the patient reclines comfortably on the exam table. The provider gently and respectfully glides the sensor over the breast with very light pressure while both the patient and clinician view the images on the SureTouch display.

 

Immediate results mean women have immediate knowledge about their breast health.

Unlike other screening tools, with SureTouch there’s no waiting for results!  Instead, immediate digitalized results are available to both the patient and the provider. With SureTouch, the patient and the provider can view the size, shape, hardness and location of breast abnormalities (or the lack of abnormalities) during the examination, thus facilitating peace of mind and, if necessary, the initiation of life-saving actions.

SureTouch enables all areas of the breast to be comfortably and accurately examined.

More than 50% of breast cancers develop in the upper outer quadrant of the breast which can be difficult to image using other imaging modalities.  SureTouch measures the reactive pressures generated by a cancerous tissue, which is more than 100 times harder than normal tissue. Because of the sensor design, SureTouch works well on all areas of the breast, even near the underarm area where the lymph nodes are located.